- Report
- May 2022
- 40 Pages
China
From €1365EUR$1,500USD£1,160GBP
- Report
- May 2022
- 40 Pages
Brazil
From €1365EUR$1,500USD£1,160GBP
- Report
- April 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- April 2022
- 190 Pages
Global
From €2271EUR$2,496USD£1,929GBP
€3245EUR$3,565USD£2,756GBP
- Report
- December 2022
- 220 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- April 2022
- 210 Pages
Global
From €2202EUR$2,419USD£1,870GBP
€3146EUR$3,456USD£2,672GBP
- Report
- January 2022
- 141 Pages
France
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP
- Book
- July 2021
- 816 Pages
- Book
- July 2020
- 416 Pages
- Book
- March 2019
- 648 Pages
- Book
- November 2018
- 1088 Pages
- Book
- August 2018
- 384 Pages
- Book
- April 2016
- 576 Pages
- Book
- December 2014
- 280 Pages
- Book
- May 2013
- 424 Pages
The Ovarian market is a segment of the Women's Health industry that focuses on the diagnosis, treatment, and prevention of ovarian diseases. It includes products and services related to the diagnosis, treatment, and prevention of ovarian cancer, ovarian cysts, and other ovarian disorders. The market also includes products and services related to fertility, contraception, and hormone replacement therapy.
The Ovarian market is driven by the increasing prevalence of ovarian diseases, the growing awareness of the importance of early diagnosis and treatment, and the increasing demand for fertility treatments. Additionally, the development of new technologies and treatments for ovarian diseases is expected to drive the market growth.
Some companies in the Ovarian market include AbbVie, AstraZeneca, Bayer, Merck, Novartis, Pfizer, and Roche. Show Less Read more
